Table 2: Therapy at Time of Surgery

Therapeutic Class Number (%)
Prednisone None 0.5-15 mg/day >15 mg/day 268 (70.7%) 104 (27.4%) 7 (1.9%)
DMARDs, Total Exposed   Methotrexate
Hydroxychloroquine
Sulfasalazine
Leflunomide
Combination DMARDs
235 (61.2%)
145 (38.1%)
117 (30.7%)
20 (5.3%)
34 (8.9%)
84 (22.1%)
Biologics, Total Exposed   Infliximab
Adalimumab
Etanercept
Golimumab
Anakinra
Abatacept
Rituximab
70 (18.4%)
14 (3.7%)
15 (3.9%)
36 (9.5%)
1 (0.3%)
2 (0.5%)
1 (0.3%)
1 (0.3%)